puits (1) thérapie (1) substitution (1) demi-vie (1) dosage (1) Development (1) Treatment (1) Complications (1) Control (1) Entacapone (1) Dopa (1) Will (1) Therapeutics (1) Parkinson's disease (1) Oscillations (1) Neurologists (1) Movement disorders (1) Monoamine oxidase--Inhibitors (1) Human beings (1) Gold standard (1) Evidence (1) Drugs (1) Dopamine (1) Day (1) Older people (1) Addition (1) Will (1) Utilization (1) Use (1)